314 related articles for article (PubMed ID: 21415544)
1. Augmentation of gene expression and production of promatrix metalloproteinase 2 by Propionibacterium acnes-derived factors in hamster sebocytes and dermal fibroblasts: a possible mechanism for acne scarring.
Sato T; Kurihara H; Akimoto N; Noguchi N; Sasatsu M; Ito A
Biol Pharm Bull; 2011; 34(2):295-9. PubMed ID: 21415544
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
Sato T; Shirane T; Noguchi N; Sasatsu M; Ito A
J Dermatol; 2012 Sep; 39(9):774-80. PubMed ID: 22394009
[TBL] [Abstract][Full Text] [Related]
3. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts.
Choi JY; Piao MS; Lee JB; Oh JS; Kim IG; Lee SC
J Invest Dermatol; 2008 Apr; 128(4):846-54. PubMed ID: 18049448
[TBL] [Abstract][Full Text] [Related]
4. Involvement of adenosine triphosphate-binding cassette subfamily B member 1 in the augmentation of triacylglycerol excretion by Propionibacterium acnes in differentiated hamster sebocytes.
Mizuno K; Akimoto N; Kawamura M; Nakase K; Noguchi N; Sato T
J Dermatol; 2017 Dec; 44(12):1404-1407. PubMed ID: 28714181
[TBL] [Abstract][Full Text] [Related]
5. Induction of inflammatory reactions by lipopolysaccharide in hamster sebaceous glands and pilosebaceous units in vivo and in vitro.
Iinuma K; Sato T; Akimoto N; Kurihara H; Ito A
Exp Dermatol; 2010 Dec; 19(12):1107-9. PubMed ID: 20726893
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.
Iinuma K; Sato T; Akimoto N; Noguchi N; Sasatsu M; Nishijima S; Kurokawa I; Ito A
J Invest Dermatol; 2009 Sep; 129(9):2113-9. PubMed ID: 19282842
[TBL] [Abstract][Full Text] [Related]
7. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes.
Li ZJ; Choi DK; Sohn KC; Seo MS; Lee HE; Lee Y; Seo YJ; Lee YH; Shi G; Zouboulis CC; Kim CD; Lee JH; Im M
J Invest Dermatol; 2014 Nov; 134(11):2747-2756. PubMed ID: 24820890
[TBL] [Abstract][Full Text] [Related]
8. Short-Chain Fatty Acids from
Sanford JA; O'Neill AM; Zouboulis CC; Gallo RL
J Immunol; 2019 Mar; 202(6):1767-1776. PubMed ID: 30737272
[TBL] [Abstract][Full Text] [Related]
9. Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity.
Lee SE; Kim JM; Jeong SK; Choi EH; Zouboulis CC; Lee SH
J Invest Dermatol; 2015 Sep; 135(9):2219-2227. PubMed ID: 25880702
[TBL] [Abstract][Full Text] [Related]
10. Cell-free extracts of Propionibacterium acnes stimulate cytokine production through activation of p38 MAPK and Toll-like receptor in SZ95 sebocytes.
Huang YC; Yang CH; Li TT; Zouboulis CC; Hsu HC
Life Sci; 2015 Oct; 139():123-31. PubMed ID: 26341693
[TBL] [Abstract][Full Text] [Related]
11. Acne vaccines targeting Propionibacterium acnes.
Kao M; Huang CM
G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
[TBL] [Abstract][Full Text] [Related]
12. Propionibacterium acnes and sebaceous lipogenesis: a love-hate relationship?
Zouboulis CC
J Invest Dermatol; 2009 Sep; 129(9):2093-6. PubMed ID: 19809423
[TBL] [Abstract][Full Text] [Related]
13. Preventative effects of antioxidants on changes in sebocytes, outer root sheath cells, and
Kwack MH; Ha DL; Lee WJ
Int J Immunopathol Pharmacol; 2022; 36():3946320221112433. PubMed ID: 35778860
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Catechols in Acteoside in the Activation of Promatrix Metalloproteinase-2 and Membrane Type-1-Matrix Metalloproteinase Expression via a Phosphatidylinositol-3-Kinase Pathway in Human Dermal Fibroblasts.
Si N; Kanazawa H; Okuyama K; Imada K; Wang H; Yang J; Zhao H; Bian B; Ito A; Sato T
Biol Pharm Bull; 2018; 41(10):1530-1536. PubMed ID: 30270322
[TBL] [Abstract][Full Text] [Related]
15. On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients.
Gloor M; Franke M
Arch Dermatol Res; 1978 Jun; 262(1):125-9. PubMed ID: 150822
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 and P. acnes: do they trigger initial acne vulgaris lesions?
Bakry OA; Samaka RM; Sebika H; Seleit I
Anal Quant Cytopathol Histpathol; 2014 Apr; 36(2):100-10. PubMed ID: 24902362
[TBL] [Abstract][Full Text] [Related]
17. Biofilms in skin infections: Propionibacterium acnes and acne vulgaris.
Coenye T; Honraet K; Rossel B; Nelis HJ
Infect Disord Drug Targets; 2008 Sep; 8(3):156-9. PubMed ID: 18782032
[TBL] [Abstract][Full Text] [Related]
18. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
19. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes.
Nagy I; Pivarcsi A; Kis K; Koreck A; Bodai L; McDowell A; Seltmann H; Patrick S; Zouboulis CC; Kemény L
Microbes Infect; 2006 Jul; 8(8):2195-205. PubMed ID: 16797202
[TBL] [Abstract][Full Text] [Related]
20. Propionibacterium acnes strain populations in the human skin microbiome associated with acne.
Fitz-Gibbon S; Tomida S; Chiu BH; Nguyen L; Du C; Liu M; Elashoff D; Erfe MC; Loncaric A; Kim J; Modlin RL; Miller JF; Sodergren E; Craft N; Weinstock GM; Li H
J Invest Dermatol; 2013 Sep; 133(9):2152-60. PubMed ID: 23337890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
